When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 50 Hits
  • Search Condition : Filter (MeSH = Combined Modality Therapy)
Species Resource
DNA material AxCA rat HGF (RDB1553) Combination gene therapy of HGF and truncated type II TGF-beta receptor for rat liver cirrhosis after partial hepatectomy.
Mice PD-1-KO-N12 (BALB/c)(RBRC00904) Immunosuppressive myeloid cells induced by chemotherapy attenuate antitumor CD4+ T-cell responses through the PD-1-PD-L1 axis.
Human and Animal Cells Electrochemotherapy is effective in the treatment of rat bone metastases.
Human and Animal Cells Combination treatments with the PKC inhibitor, enzastaurin, enhance the cytotoxicity of the anti-mesothelin immunotoxin, SS1P.
Human and Animal Cells Curcumin and 5-fluorouracil-loaded, folate- and transferrin-decorated polymeric magnetic nanoformulation: a synergistic cancer therapeutic approach, accelerated by magnetic hyperthermia.
Human and Animal Cells NKG2D-directed cytokine-activated killer lymphocyte therapy combined with gemcitabine for patients with chemoresistant metastatic solid tumors.
Human and Animal Cells Intraperitoneal administration of a small interfering RNA targeting nuclear factor-kappa B with paclitaxel successfully prolongs the survival of xenograft model mice with peritoneal metastasis of gastric cancer.
Human and Animal Cells SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma.
Human and Animal Cells Combining cetuximab with killer lymphocytes synergistically inhibits human cholangiocarcinoma cells in vitro.
Human and Animal Cells Enhanced antitumoral activity of oncolytic herpes simplex virus with gemcitabine using colorectal tumor models.
Human and Animal Cells Application of Candida solubilized cell wall beta-glucan in antitumor immunotherapy against P815 mastocytoma in mice.
Mice PD-1-KO-N12 (BALB/c) Chemotherapy rescues tumor-driven aberrant CD4+ T-cell differentiation and restores an activated polyfunctional helper phenotype.
Mice PD-1-KO-N12 (BALB/c) (RBRC00904) Polyfunctional CD4⁺ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy.
Human and Animal Cells Hep G2 (RCB0459) HuH-7 (RCB1366) EpCAM- and EGFR-targeted selective gene therapy for biliary cancers using Z33-fiber-modified adenovirus.
Human and Animal Cells MKN45 (RCB1001) Epigenetic modulation enhances the therapeutic effect of anti-IL-13R(alpha)2 antibody in human mesothelioma xenografts.
Human and Animal Cells HOS (RCB0992) Hyperthermia enhances the effect of β-lapachone to cause γH2AX formations and cell death in human osteosarcoma cells.
Human and Animal Cells T3M-4 (RCB1021) Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer.
Human and Animal Cells MKN45 (RCB1001) MKN74 (RCB1002) HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy.
DNA material AxCAUT (RDB02050) , pAxcwit (RDB03120) Oncolytic gene therapy combined with double suicide genes for human bile duct cancer in nude mouse models.
DNA material pMFGmIL2 (RDB01441) , pMFGmIFN gamma (RDB01454) , pBluescript SKII+mGM-CSF Mouse GM-CSF cDNA (RDB01469) Immunotherapy for lung metastases of murine renal cell carcinoma: synergy between radiation and cytokine-producing tumor vaccines.